WAM
VRTX icon

Weatherly Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Weatherly Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Hold
1,184
– – 0.04% 127
2026
Q1 		$529K Hold
1,184
– – 0.04% 129
2025
Q4 		$537K Sell
1,184
-347
-23% -$150K 0.04% 129
2025
Q3 		$600K Buy
+1,531
New +$640K 0.05% 126

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Weatherly Asset Management's VRTX Position: Q2 2026 in Review

Weatherly Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,184 shares worth $588K. The position accounts for 0.04% of the portfolio, ranked #127.

Weatherly Asset Management first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $600K in Q3 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Weatherly Asset Management held 1,184 shares of Vertex Pharmaceuticals worth $588K as of Q2 2026.
  • Weatherly Asset Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.04% of Weatherly Asset Management's portfolio in Q2 2026, its #127 holding.
  • Weatherly Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Weatherly Asset Management's Vertex Pharmaceuticals position peaked at $600K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Weatherly Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.